Your browser doesn't support javascript.
loading
Translation and validation of the Myasthenia Gravis Activities of Daily Living Questionnaire: Latvian version.
Grosmane, Arta; Roze, Ieva; Roddate, Marija; Kauke, Gundega; Zukova, Violeta; Glazere, Ieva; Zolovs, Maksims; Kenina, Viktorija.
Affiliation
  • Grosmane A; Department of Neurology, Pauls Stradins Clinical University Hospital, Riga, Latvia.
  • Roze I; Department of Residency, Riga Stradins University, Riga, Latvia.
  • Roddate M; Department of Neurology, Pauls Stradins Clinical University Hospital, Riga, Latvia.
  • Kauke G; Department of Neurology, Pauls Stradins Clinical University Hospital, Riga, Latvia.
  • Zukova V; Department of Biology and Microbiology, Riga Stradins University, Riga, Latvia.
  • Glazere I; Department of Neurology, Pauls Stradins Clinical University Hospital, Riga, Latvia.
  • Zolovs M; Department of Residency, Riga Stradins University, Riga, Latvia.
  • Kenina V; Department of Neurology, Pauls Stradins Clinical University Hospital, Riga, Latvia.
Front Neurol ; 15: 1397603, 2024.
Article de En | MEDLINE | ID: mdl-38859974
ABSTRACT

Introduction:

Our aim was to translate, adapt and validate the Myasthenia Gravis Activities of Daily Living scale into the Latvian language and to evaluate this instrument (MG-ADL-L) in terms of construct validity and reliability.

Methods:

We enrolled patients with a confirmed MG diagnosis, who could speak Latvian fluently. We performed translation and adaptation according to the cross-cultural adaptation guidelines for self-reported measures. The patients were evaluated by a physician according to the Myasthenia Gravis Foundation of America classification (MGFA) and using the Myasthenia Gravis Composite Score (MGCS). Patients were asked to complete the MG-ADL-L and the 15-item Myasthenia Gravis Quality of Life (MGQOL15) Internal consistency was evaluated based on Cronbach's α, reproducibility-Cohen's weighted kappa and construct validity-Spearman's correlation between the MG-ADL-L and the MGQOL15 and MGCS. We used the Kruskal-Wallis H test to compare the MG-ADL-L score distribution between the MGFA groups.

Results:

38 enrolled patients in the study. There was an acceptable internal consistency (Cronbach's α = 0.76) and moderate to very good agreement between the test and retest scores (Cohen's weighted kappa = 0.54 and 0.81). The MG-ADL-L showed a moderate positive correlation with the MGQOL15 (r = 0.5, p = 0.001) and the MGCS (r = 0.62, p < 0.001). There was a significant difference in MG-ADL-L scores between the MGFA groups (p = 0.007).

Discussion:

The MG-ADL-L is a valid and reliable self-reported scale to assess and evaluate symptom severity and the impact of the disease on the lives of patients with MG.
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Front Neurol Année: 2024 Type de document: Article Pays d'affiliation: Lettonie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Front Neurol Année: 2024 Type de document: Article Pays d'affiliation: Lettonie